Non-small cell lung cancer (NSCLC) is one of two main types of lung cancer. Some lung cancers spread to other parts of the body before they are diagnosed. A cancer that has spread is called ‘metastatic’. New lung cancer treatments are being developed that directly target the gene mutations that control how cancers grow and spread. The most important gene mutations in cancer are called ‘driver mutations’. In NSCLC, this includes KRAS mutations, which can be used as targets for treatment. There are new treatments designed for lung cancers with a KRAS mutation that are already available. And more are being developed. Treatments in development are tested in clinical trials. There are several different phases of clinical trials that people with cancer can take part in. This booklet aims to help patients with NSCLC understand their options so that they can talk to their doctors, nurses, and medical team about their cancer and its treatment.
"synopsis" may belong to another edition of this title.
Seller: Majestic Books, Hounslow, United Kingdom
Condition: Used. Seller Inventory # 397337758
Quantity: 1 available
Seller: moluna, Greven, Germany
Kartoniert / Broschiert. Condition: New. Non-small cell lung cancer (NSCLC) is one of two main types of lung cancer. Some lung cancers spread to other parts of the body before they are diagnosed. A cancer that has spread is called metastatic . New lung cancer treatments are being developed that d. Seller Inventory # 839053629
Quantity: Over 20 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Neuware - Non-small cell lung cancer (NSCLC) is one of two main types of lung cancer. Some lung cancers spread to other parts of the body before they are diagnosed. A cancer that has spread is called 'metastatic'. New lung cancer treatments are being developed that directly target the gene mutations that control how cancers grow and spread. The most important gene mutations in cancer are called 'driver mutations'. In NSCLC, this includes KRAS mutations, which can be used as targets for treatment. There are new treatments designed for lung cancers with a KRAS mutation that are already available. And more are being developed. Treatments in development are tested in clinical trials. There are several different phases of clinical trials that people with cancer can take part in. This booklet aims to help patients with NSCLC understand their options so that they can talk to their doctors, nurses, and medical team about their cancer and its treatment. Seller Inventory # 9783318072495
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Fast Facts for Patients: Non-small Cell Lung Cancer with KRAS Mutation | Anne-Marie Baird (u. a.) | Taschenbuch | Englisch | 2023 | Karger | EAN 9783318072495 | Verantwortliche Person für die EU: Karger Freiburg, Wilhelmstr. 20a, 79098 Freiburg, orders[at]karger[dot]com | Anbieter: preigu. Seller Inventory # 126733125